Skip to main content

Alcaraz Lopez, Carlos Jorge

Institutions of which they are part

Senior researcher
Rheumatology
Vall Hebron Institut de Recerca

Alcaraz Lopez, Carlos Jorge

Institutions of which they are part

Senior researcher
Rheumatology
Vall Hebron Institut de Recerca

Related news

The new therapeutic strategy aims at maintaining the efficacy of thalidomide while avoiding its main systemic adverse effects.

The event, held as part of World Lupus Day, incorporated the perspective of people living with the disease to address the challenges associated with lupus.

The global biopharmaceutical company UCB has acquired the data and clinical knowledge business of IMIDomics, a spin-off of the Vall d’Hebron Institute of Research (VHIR).

Related professionals

Campos Estela, Berta

Campos Estela, Berta

Research assistant
Genetics Medicine
Read more
Granda Soto, Alejandro

Granda Soto, Alejandro

Administration and Management
Clinical Neuroimmunology
Read more
Rivera Sanchez, Laura

Rivera Sanchez, Laura

Administration and Management
Stroke research
Read more
Martinez  Lopez, Maria Pilar

Martinez Lopez, Maria Pilar

Research assistant
General Surgery
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.